Common Mistakes in the Clinical Use of Bone Mineral Density Testing

Overview

Journal Nat Clin Pract Rheumatol

Specialty Rheumatology

Date 2008 Oct 22

PMID 18936788

Citations 24

Authors

E Michael Lewiecki

Nancy E Lane

Affiliations

Soon will be listed here.

Abstract

Bone mineral density (BMD) testing is used to diagnose osteoporosis, assess fracture risk and monitor changes in BMD over time. A variety of devices and technologies are used to measure BMD or other surrogate markers of bone strength. Measurements obtained with these devices are often reported according to different proprietary standards, and the comparability of values obtained with different instruments is often poor. In addition, there is a high degree of variability in the skills of the technologists performing the tests and the clinicians interpreting the results. Heterogeneity in the guidelines for using BMD measurements together with poor-quality BMD testing and reporting can result in inappropriate clinical decisions, causing unnecessary worry and expense for the patient and possible harm due to unnecessary treatment or treatment being withheld. This Review describes and discusses the mistakes commonly made in BMD testing, and emphasizes the importance of maintaining high-quality standards in order to optimize patient management.

Citing Articles

Quality assessment in bone densitometry: a case of incorrect hip analysis.

Xu H, Gabriel M, James J BJR Case Rep. 2024; 10(6):uaae038.

PMID: 39494353 PMC: 11530240. DOI: 10.1093/bjrcr/uaae038.

Microwave Vertebrae Strength Probe Development: Robust and Fast Phase Unwrapping Technique.

Meaney P, Mattsson V, Augustine R, Brisby H IEEE J Electromagn RF Microw Med Biol. 2024; 8(1):78-83.

PMID: 39371048 PMC: 11452015. DOI: 10.1109/jerm.2024.3363148.

Real-life effects of pharmacological osteoporosis treatments on bone mineral density by quantitative computed tomography.

Boehm E, Sauer C, Baur-Melnyk A, Biebl J, Harada S, Wegener B J Bone Miner Metab. 2024; 42(6):741-753.

PMID: 39287797 DOI: 10.1007/s00774-024-01553-z.

Predicting Structural Properties of Cortical Bone by Combining Ultrasonic Attenuation and an Artificial Neural Network (ANN): 2-D FDTD Study.

Mohanty K, Yousefian O, Karbalaeisadegh Y, Ulrich M, Muller M Image Anal Recognit. 2024; 11662:407-417.

PMID: 38288296 PMC: 10823500. DOI: 10.1007/978-3-030-27202-9_37.

Transmission-Based Vertebrae Strength Probe Development: Far Field Probe Property Extraction and Integrated Machine Vision Distance Validation Experiments.

Meaney P, Augustine R, Welteke A, Pfrommer B, Pearson A, Brisby H Sensors (Basel). 2023; 23(10).

PMID: 37430734 PMC: 10220895. DOI: 10.3390/s23104819.

References

Cranney A, Tugwell P, Wells G, Guyatt G . Meta-analyses of therapies for postmenopausal osteoporosis. I. Systematic reviews of randomized trials in osteoporosis: introduction and methodology. Endocr Rev. 2002; 23(4):496-507. DOI: 10.1210/er.2001-1002. View

Hans D, Shepherd J, Schwartz E, Reid D, Blake G, Fordham J . Peripheral dual-energy X-ray absorptiometry in the management of osteoporosis: the 2007 ISCD Official Positions. J Clin Densitom. 2008; 11(1):188-206. DOI: 10.1016/j.jocd.2007.12.012. View

Lenchik L, Kiebzak G, Blunt B . What is the role of serial bone mineral density measurements in patient management?. J Clin Densitom. 2002; 5 Suppl:S29-38. DOI: 10.1385/jcd:5:3s:s29. View

Lotz J, Cheal E, Hayes W . Fracture prediction for the proximal femur using finite element models: Part I--Linear analysis. J Biomech Eng. 1991; 113(4):353-60. DOI: 10.1115/1.2895412. View

Mazess R, Chesnut 3rd C, McClung M, Genant H . Enhanced precision with dual-energy X-ray absorptiometry. Calcif Tissue Int. 1992; 51(1):14-7. DOI: 10.1007/BF00296209. View

. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994; 843:1-129. View

Marshall D, Johnell O, Wedel H . Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996; 312(7041):1254-9. PMC: 2351094. DOI: 10.1136/bmj.312.7041.1254. View

Njeh C, Fuerst T, Hans D, Blake G, Genant H . Radiation exposure in bone mineral density assessment. Appl Radiat Isot. 1999; 50(1):215-36. DOI: 10.1016/s0969-8043(98)00026-8. View

Lewiecki E . Premenopausal bone health assessment. Curr Rheumatol Rep. 2005; 7(1):46-52. DOI: 10.1007/s11926-005-0008-9. View

10.

Lewiecki E . Update on bone density testing. Curr Osteoporos Rep. 2005; 3(4):136-42. DOI: 10.1007/s11914-996-0016-3. View

11.

Leslie W, Adler R, Fuleihan G, Hodsman A, Kendler D, McClung M . Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: the 2005 ISCD Official Positions. J Clin Densitom. 2006; 9(1):22-30. DOI: 10.1016/j.jocd.2006.05.004. View

12.

Shepherd J, Lu Y, Wilson K, Fuerst T, Genant H, Hangartner T . Cross-calibration and minimum precision standards for dual-energy X-ray absorptiometry: the 2005 ISCD Official Positions. J Clin Densitom. 2006; 9(1):31-6. DOI: 10.1016/j.jocd.2006.05.005. View

13.

Lewiecki E, Richmond B, Miller P . Uses and misuses of quantitative ultrasonography in managing osteoporosis. Cleve Clin J Med. 2006; 73(8):742-6, 749-52. DOI: 10.3949/ccjm.73.8.742. View

14.

Lewiecki E, Binkley N, Petak S . DXA quality matters. J Clin Densitom. 2006; 9(4):388-92. DOI: 10.1016/j.jocd.2006.07.002. View

15.

Baim S, Binkley N, Bilezikian J, Kendler D, Hans D, Lewiecki E . Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom. 2008; 11(1):75-91. DOI: 10.1016/j.jocd.2007.12.007. View

16.

Engelke K, Adams J, Armbrecht G, Augat P, Bogado C, Bouxsein M . Clinical use of quantitative computed tomography and peripheral quantitative computed tomography in the management of osteoporosis in adults: the 2007 ISCD Official Positions. J Clin Densitom. 2008; 11(1):123-62. DOI: 10.1016/j.jocd.2007.12.010. View

17.

Krieg M, Barkmann R, Gonnelli S, Stewart A, Bauer D, Del Rio Barquero L . Quantitative ultrasound in the management of osteoporosis: the 2007 ISCD Official Positions. J Clin Densitom. 2008; 11(1):163-87. DOI: 10.1016/j.jocd.2007.12.011. View

18.

Faulkner K, von Stetten E, Miller P . Discordance in patient classification using T-scores. J Clin Densitom. 1999; 2(3):343-50. DOI: 10.1385/jcd:2:3:343. View

19.

Wasnich R, Miller P . Antifracture efficacy of antiresorptive agents are related to changes in bone density. J Clin Endocrinol Metab. 2000; 85(1):231-6. DOI: 10.1210/jcem.85.1.6267. View

20.

. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Arthritis Rheum. 2001; 44(7):1496-503. DOI: 10.1002/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5. View